BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23958588)

  • 41. Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection.
    Song BC; Cui XJ; Kim H
    Intervirology; 2005; 48(2-3):133-7. PubMed ID: 15812186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo ME; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
    J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
    Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
    Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
    You J; Sriplung H; Chongsuvivatwong V; Geater A; Zhuang L; Huang JH; Chen HY; Yu L; Tang BZ
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status.
    Halfon P; Bourlière M; Pol S; Benhamou Y; Ouzan D; Rotily M; Khiri H; Renou C; Pénaranda G; Saadoun D; Thibault V; Serpaggi J; Varastet M; Tainturier MH; Poynard T; Cacoub P
    J Viral Hepat; 2006 May; 13(5):329-35. PubMed ID: 16637864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.
    Hung CH; Chen CH; Lee CM; Hu TH; Lu SN; Wang JH; Huang CM
    Intervirology; 2013; 56(5):316-24. PubMed ID: 23838434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
    Chambal LM; Gudo ES; Carimo A; Corte Real R; Mabunda N; Maueia C; Vubil A; Zicai AF; Bhatt N; Antunes F
    PLoS One; 2017; 12(7):e0181836. PubMed ID: 28759595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan.
    Sakugawa H; Nakasone H; Nakayoshi T; Orito E; Mizokami M; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Miyagi Y
    J Med Virol; 2002 Aug; 67(4):484-9. PubMed ID: 12115993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY).
    Piroth L; Sène D; Pol S; Goderel I; Lacombe K; Martha B; Rey D; Loustau-Ratti V; Bergmann JF; Pialoux G; Gervais A; Lascoux-Combe C; Carrat F; Cacoub P
    AIDS; 2007 Jun; 21(10):1323-31. PubMed ID: 17545709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.
    Chadwick D; Ankcorn M; Sarfo F; Phillips R; Fox Z; Garcia A; Appiah L; Bedu-Addo G; Geretti AM
    J Antimicrob Chemother; 2012 Dec; 67(12):2939-42. PubMed ID: 22915461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.
    Zeng G; Wang Z; Wen S; Jiang J; Wang L; Cheng J; Tan D; Xiao F; Ma S; Li W; Luo K; Naoumov NV; Hou J
    J Viral Hepat; 2005 Nov; 12(6):609-17. PubMed ID: 16255762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
    Firnhaber C; Chen CY; Evans D; Maskew M; Schulz D; Reyneke A; Kramvis A
    Int J Infect Dis; 2012 Apr; 16(4):e268-72. PubMed ID: 22305987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
    Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K
    J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversibility of cirrhosis in HIV/HBV coinfection.
    Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S
    Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
    Pradat P; Le Pogam MA; Okon JB; Trolliet P; Miailhes P; Brochier C; Maynard M; Bailly F; Zoulim F; Cotte L
    J Viral Hepat; 2013 Sep; 20(9):650-7. PubMed ID: 23910650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.